首页> 外国专利> METHODS TO TREAT A SUBJECT SUBJECT TO HYMENOPTER POISON, HEMOLYSIS, MASTOCYTE DISEASE AND ACUTE INJURY TO TREAT A COBRA POISONING, A SUBJECT THAT IS AT RISK TO OR SOMEBODY AND LEAF DE EDEM NEURONAL, TO REDUCE RISK OF HEMOLYSIS IN A SUBJECT AND HEMOLYSIS IN A SUBJECT, COMPOSITION, KIT, AND USE OF A PLA2 INHIBITOR.

METHODS TO TREAT A SUBJECT SUBJECT TO HYMENOPTER POISON, HEMOLYSIS, MASTOCYTE DISEASE AND ACUTE INJURY TO TREAT A COBRA POISONING, A SUBJECT THAT IS AT RISK TO OR SOMEBODY AND LEAF DE EDEM NEURONAL, TO REDUCE RISK OF HEMOLYSIS IN A SUBJECT AND HEMOLYSIS IN A SUBJECT, COMPOSITION, KIT, AND USE OF A PLA2 INHIBITOR.

机译:治疗对象的原因包括:处女膜有毒,溶血,乳糜泻和急性损伤,可治疗眼镜蛇中毒,这是一种可能或具有某种危险的疾病,而脑叶神经病,减少溶血和溶血的病因PLA2抑制剂的用途,组成,套件和使用。

摘要

Methods are provided for treating pathological conditions causing hemolysis, cerebral edema, acute kidney injury, and non-anaphylactic shock, including poisoning, trauma, cerebral malaria, and mast cell disease, using at least one pla2 inhibitor, alone or in combination with others. agents. The unexpected versatility of pla2 inhibitors, their dosage forms and combinations make them candidates for essential medicines for the world's development.
机译:提供了使用至少一种pla2抑制剂单独或与其他药物组合使用来治疗引起溶血,脑水肿,急性肾损伤和非过敏性休克的病理状况的方法,包括中毒,创伤,脑疟疾和肥大细胞疾病。代理商。 pla2抑制剂的出乎意料的多功能性,其剂型和组合使其成为世界发展的基本药物的候选者。

著录项

  • 公开/公告号BR112018072162A2

    专利类型

  • 公开/公告日2019-02-12

    原文格式PDF

  • 申请/专利权人 OPHIREX INC;

    申请/专利号BR20181172162

  • 发明设计人 MATTHEW R. LEWIN;

    申请日2017-05-01

  • 分类号A61K31/16;A61K31/19;A61K31/404;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:25

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号